PROCLAIM-CX-2009: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2009 for Patients With Selected Solid Tumors

Clinical trial NCT03149549 · TERMINATED

Trial details

NCT number: NCT03149549
Sponsor: CytomX Therapeutics
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Solid Tumor, Adult Breast Cancer Non Small Cell Lung Cancer Head and Neck Cancer Ovarian Cancer

Start date: 2017-06-01
Primary completion: 2020-09-10
Enrollment: 99

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.